[Skip to Navigation]
JAMA Dermatology Clinicopathological Challenge
October 2014

Progressive Widespread Cutaneous Telangiectasias

Author Affiliations
  • 1University of Alabama School of Medicine, Birmingham
  • 2Department of Dermatology, University of Alabama at Birmingham, Birmingham
JAMA Dermatol. 2014;150(10):1103-1104. doi:10.1001/jamadermatol.2014.1183

A woman in her 50s presented with “speckled” red lesions on her bilateral arms, lower legs, and feet. They had first appeared on her lower legs 15 years ago and were slowly increasing in number and spreading to involve her feet and bilateral upper extremities. The patient denied tenderness, pruritus, and edema. She reported no family history of this problem and denied any personal history of anemia, epistaxis, hematemesis, melena, hematochezia, or hemoptysis. She had a medical history of hypertension, hyperlipidemia, and tobacco abuse, requiring treatment with losartan and atorvastatin.

Add or change institution
1 Comment for this article
Vascular Laser is the Treatment of Choice for GET
Philip Bekhor | Director Laser Unit Dept. Derm. RCH Melbourne Australia

A nice review of GET, however the treatment discussion lacks perspective. In reality, vascular laser works very well. My experience with 595nm Pulsed Dye Laser for this condition demonstrates very high response rates at the lower end of the fluence range. I suspect than any vascular laser or IPL operating in the 500 to 600 nm range with a large treatment spot size would be effective. In summary, vascular laser is the treatment of choice and the bizarre collection of medications that have been tried are simply an historical curiosity.